NAT10 and hepatocellular carcinoma: Among the liver cancer chemotherapeutic drugs oxaliplatin and doxorubicin, ACLY can be acetylated by NAT10 at lysine 468, which confers resistance to chemotherapy in HCC cells and mouse xenografts.